Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-12

Clinical Trial Update: Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults [NA]

View source ↗

Summary

Clinical trial update for PRISM self neuro-modulation in adults with Attention Deficit/Hyperactivity Disorder (ADHD); study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRISM Self Neuro-Modulation (Process-instructed Self Neuro-Modulation)

Snippet

Sponsor: NYU Langone Health | Conditions: Attention Deficit Hyper Activity | NA | Status: COMPLETED | Results posted: 2023-12-12